Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Signs Marketing Agreements with Asian, European Partners; Opens European Sales Office

NEW YORK, Feb. 2 (GenomeWeb News) - NuGen Technologies has signed agreements with MediBic of Japan and TouchDown Biomarketing in Europe to help it market and sell its RNA-amplification products in Asia and Europe, respectively, the company said yesterday.

 

San Carlos, Calif.-based NuGen also said it has opened a sales office in Europe, which will be managed by TouchDown. NuGen's European sales team will work with TouchDown to launch the company's RNA-amplification systems in the European market.

 

MediBic, a Japanese life sciences and pharmacogenomics consulting company, will help NuGen introduce its Ovation RNA-amplification products throughout Asia.

 

TouchDown is based in Gendt, The Netherlands, and MediBic is located in Tokyo.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.